- Thinly traded nano cap Nivalis Therapeutics (NVLS) is up 7% premarket on increased volume. After the close yesterday, it announced that the board has initiated a process to "explore and review a range of strategic alternatives" to boost shareholder value.
- Ladenburg Thalmann is advising.
Nivalis exploring strategic alternatives; shares perk up 7% premarket
Recommended For You
More Trending News
About ALPN Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ALPN | - | - |
Alpine Immune Sciences, Inc. |